Mumps Virus Antibody, IgM, Serum
Use
The test is useful for the laboratory diagnosis of mumps virus infection. It detects the presence of IgM-class antibodies to mumps virus, which may support a clinical diagnosis of recent or acute infection with the virus.
Special Instructions
Not provided.
Limitations
Results must always be interpreted together with other clinical and laboratory findings. Serum specimens drawn during the acute phase of infection may be negative by serological tests. All positive results must be interpreted with care, as some false-positive results or heterotypical responses of the IgM have been seen in the serum of pregnant women or in patients with an acute infection caused by cytomegalovirus, herpes simplex virus, measles, rubella, and parvovirus. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
FDA ApprovedNew York Approved
Methodology
Immunoassay (EIA)
Biomarkers
Mumps Virus IgM
Antibody
LOINC Codes
- 6478-2 - MuV IgM Ser Ql IA
- 6478-2 - MuV IgM Ser Ql IA
- 25419-3 - MuV IgM Ser IA-aCnc
Result Turnaround Time
1-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into plastic vial.
Causes for Rejection
Gross hemolysis, gross lipemia, heat-inactivated specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 14 days |